Search Results - "Simonsen CS"

Managing Relapsing Multiple Sclerosis Across the Lifespan: A Narrative Review with Expert Opinion from Norway.

Authors: Simonsen CS König M Bjelland SH et al.

Source: Neurology and therapy [Neurol Ther] 2026 Jun; Vol. 15 (3), pp. 907-923. Date of Electronic Publication: 2026 Mar 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: New Zealand NLM ID: 101637818 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8253 (Print) Linking ISSN: 21936536 NLM ISO Abbreviation: Neurol Ther Subsets: PubMed not MEDLINE

Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort study.

Authors: Simonsen CS Flemmen HØ Broch L et al.

Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Apr; Vol. 31 (4), pp. 398-407. Date of Electronic Publication: 2025 Feb 17.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

Paternal exposure to antidiabetic medications during reproductive period and adverse birth outcomes: A meta-analysis and systematic review.

Authors: Simonsen CS Eisenberg ML Lindahl-Jacobsen R

Source: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2025 Dec; Vol. 315, pp. 114747. Date of Electronic Publication: 2025 Oct 02.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis.

Authors: Hartung, Hans-Peter Robertson, Derrick Steinman, Lawrence et al.

Source: Neurology & Therapy. Jun2026, Vol. 15 Issue 3, p1081-1097. 17p.

Economic burden of secondary progressive multiple sclerosis: DISCOVER study.

Authors: Oreja-Guevara, Celia Meca-Lallana, José E. Gómez-Estévez, Irene et al.

Source: BMC Health Services Research. 4/9/2025, Vol. 25 Issue 1, p1-14. 14p.

No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review].

Authors: Newsome, Scott D. Binns, Cherie Kaunzner, Ulrike W. et al.

Source: Neurology & Therapy. Dec2023, Vol. 12 Issue 6, p1909-1935. 27p.

Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis.

Authors: Rezaee, Mehdi Ravangard, Ramin Mojtabaeian, Seyyed Morteza et al.

Source: BMC Health Services Research. 10/29/2024, Vol. 24 Issue 1, p1-17. 17p.

Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice.

Authors: Yamout, Bassem Alroughani, Raed Inshasi, Jihad et al.

Source: Neurology & Therapy. Oct2024, Vol. 13 Issue 5, p1321-1335. 15p.

Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri^®) Dosing: NOVA Phase IIIb Extension Study (Part 2).

Authors: Wiendl, Heinz Foley, John Defer, Gilles et al.

Source: Neurology & Therapy. Oct2024, Vol. 13 Issue 5, p1385-1401. 17p.

Association of cytokine levels with treatment duration and patient family history in Egyptian multiple sclerosis patients.

Authors: Mohsen, Esraa Haffez, Hesham Ahmed, Sandra et al.

Source: Scientific Reports. 3/2/2026, Vol. 16 Issue 1, p1-11. 11p.

Psychiatric comorbidities in multiple sclerosis patients and their relationship with clinical variables: A university hospital sample.

Authors: Asut, Gonca Iyigundogdu, Ilkin

Source: Dusunen Adam: Journal of Psychiatry & Neurological Sciences. Mar2026, Vol. 39 Issue 1, p24-32. 9p.

Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study.

Authors: Freedman DE Oh J Einstein G et al.

Source: Journal of neurology [J Neurol] 2025 May 04; Vol. 272 (5), pp. 375. Date of Electronic Publication: 2025 May 04.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.

Authors: Oliva-Nacarino, Pedro Simal Antuña, Marina Santos Varela, Carmen et al.

Source: BMC Neurology. 3/22/2025, Vol. 25 Issue 1, p1-9. 9p.

Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple Sclerosis.

Authors: Hernández, Francisco Javier Barrero Lahoz, Ángel José Morales Gutiérrez, Cristina Serrano et al.

Source: Patient Preference & Adherence. Mar2025, Vol. 18, p715-727. 13p.

Serum Interleukin-40 and Soluble CD40 Ligand as Complementary Biomarkers for Disease Activity in Multiple Sclerosis Patients.

Alternate Title: Multipl Skleroz Hastalarında Hastalık Aktivitesinin Tamamlayıcı Biyobelirteçleri Olarak Serum.

Authors: NEAMAH, Mustafa Ziyad SHARQUIE, Inas K GAWWAM, Gheyath AL

Source: Medeniyet Medical Journal. 2025, Vol. 40 Issue 4, p226-234. 9p.

Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis.

Authors: Nyári, Aliz Kokas, Zsófia Szamosi, Szabolcs et al.

Source: Neurological Sciences. Jan2025, Vol. 46 Issue 1, p325-334. 10p.

Subjects: Fine motor ability, Quality of service, Logistic regression analysis, Medical sciences, Public health

Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion.

Authors: Mantegazza, Renato Saccà, Francesco Antonini, Giovanni et al.

Source: Neurological Sciences. Dec2024, Vol. 45 Issue 12, p5671-5683. 13p.

Subjects: Cholinergic receptors, Therapeutics, Protein-tyrosine kinases, Immunosuppressive agents, Complement activation, Eculizumab, Myasthenia gravis, Off-label use (Drugs)

Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population.

Authors: Simonsen CS Flemmen HØ Broch L et al.

Source: Frontiers in neurology [Front Neurol] 2022 Nov 14; Vol. 13, pp. 1034056. Date of Electronic Publication: 2022 Nov 14 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.

Authors: Simonsen CS Flemmen HØ Broch L et al.

Source: Frontiers in neurology [Front Neurol] 2021 Jun 17; Vol. 12, pp. 693017. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2295 (Print) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: PubMed not MEDLINE

High prevalence of fatigue in contemporary patients with multiple sclerosis.

Authors: Broch L Simonsen CS Flemmen HØ et al.

Source: Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2021 Mar 18; Vol. 7 (1), pp. 2055217321999826. Date of Electronic Publication: 2021 Mar 18 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Sage Publications Ltd Country of Publication: United States NLM ID: 101668877 Publication Model: eCollection Cited Medium: Print ISSN: 2055-2173 (Print) Linking ISSN: 20552173 NLM ISO Abbreviation: Mult Scler J Exp Transl Clin Subsets: PubMed not MEDLINE